|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
EXP |
Ritanserin results in increased expression of BDNF mRNA |
CTD |
PMID:12393228 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
multiple interactions affects binding |
ISO EXP |
Ritanserin binds to and results in decreased activity of HTR2A protein Ritanserin binds to HTR2A protein |
CTD |
PMID:8937629 PMID:17031071 |
|
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Htr2b |
5-hydroxytryptamine receptor 2B |
multiple interactions |
ISO |
Ritanserin binds to and results in decreased activity of HTR2B protein |
CTD |
PMID:10978843 |
|
NCBI chr 9:86,735,793...86,756,638
Ensembl chr 9:86,742,102...86,755,108
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
multiple interactions |
ISO |
[Ritanserin binds to and results in decreased activity of HTR7 protein] inhibits the reaction [5-carboxamidotryptamine results in increased abundance of Cyclic AMP] |
CTD |
PMID:14578406 |
|
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions |
ISO |
Ritanserin inhibits the reaction [KCNH2 protein results in increased transport of Thallium] |
CTD |
PMID:19583963 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Pdyn |
prodynorphin |
increases expression |
EXP |
Ritanserin results in increased expression of PDYN mRNA |
CTD |
PMID:9526047 |
|
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
decreases localization |
ISO |
Ritanserin results in decreased localization of SOX17 protein |
CTD |
PMID:24154490 |
|
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
|
|